Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic: Risk Analysis from the PSO-BIO-COVID Observational Study (Q102215156)
Jump to navigation
Jump to search
scientific article published on 20 November 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic: Risk Analysis from the PSO-BIO-COVID Observational Study |
scientific article published on 20 November 2020 |
Statements
Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic: Risk Analysis from the PSO-BIO-COVID Observational Study (English)
Iris Zalaudek
Aurora Parodi
Paola Savoia
1 reference
Giuseppe Argenziano
Paolo Pigatto
Pietro Quaglino
Concetta Potenza
Franco Rongioletti
Pietro Rubegni
Maria Concetta Fargnoli
Giuseppe Micali
Stefano Piaserico
Gabriella Fabbrocini
Paolo Gisondi
Angelo Valerio Marzano
Andrea Conti
Federico Bardazzi
Luca Stingeni
Francesco Loconsole
Maria Teresa Rossi
Maria Rita Bongiorno
Claudio Feliciani
Paolo Amerio
Steven Paul Nisticò
Sandra Giustini
Serafinella Patrizia Cannavo'
Giulia Rech
Francesca Prignano
Annamaria Offidani
Maurizio Lombardo
Luca Bianchi
Ketty Peris
20 November 2020
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference